Insulin Delivery Device Market Comprehensive Review of its Applications Growth Opportunities and Future Prospects

03/mag/2019 05:49:36 Pramod Kumar Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The growing prevalence of diabetes, the growing geriatric population, the increasing prevalence of obesity, the technological development of the market.

Insulin delivery device, insulin pump, insulin pump and others. The insulin pen segment accounted for the major market share in the global market in 2015, and the insulin pump segment is expected to witness the highest growth during 2016-2022.

Request for a sample of this research report:

Various initiatives, such as programs, activities and campaigns, are implemented by IDF, NGOs, diabetes associations and health departments to create awareness among people about the effects of diabetes. One such example is a major initiative taken at a global level in the form of World Diabetes Day; celebrated on 14th November each year. World Diabetes Day is a key campaign led by IDF and its member associations, such as the (American Diabetes Association) ADA, Diabetes UK, Diabetes Australia, Diabetes South Africa, the Canadian Diabetes Association (CDA), Diabetes New Zealand, and Diabetic Association of India.

Make inquiry before buying the report:

Insulin pen needle has single use, although many diabetic patients re-use needle for delivery of insulin. The re-use of risk-free fine needle tips Similarly, the risk associated with jet injectors is accuracy of insulin dosage and improper injection. Improper injection of insulin can lead to altered absorption of insulin in the blood stream and bruising. Hence, these risks and complications associated with delivery devices are inhibiting the growth of the insulin delivery device market.

Some of the key companies operating in the insulin delivery device market include Novo Nordisk A / S, Medtronic PLC, Abbott Laboratories, Eli Lilly and Company, Insulet Corporation, Sanofi SA, Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd. , Animas Corporation, B. Braun Melsungen AG, and Ypsomed Holdings AG.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P & S as an enterprising research and consulting company, believes in providing thorough analysis on the ever-changing market scenario, to empowering companies to make informed decisions and base their business strategies with astuteness.


P&S Intelligence

Toll-free: + 1-888-778-7886 (USA / Canada)          

International: + 1-347-960-6455



Connect with us: LinkedIn | Twitter | Facebook

blog comments powered by Disqus è un servizio offerto da Factotum Srl